Recital 25, Regulation (EU) 2021/522

In forcesince 24 Mar 2021

It should be possible to support studies on the influence of gender on the characteristics of diseases in order to contribute to improving knowledge and education in that area, thereby improving prevention, diagnosis, monitoring and treatment.